Stay updated on Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov page’s footer revision label was updated from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check11 days agoChange DetectedThe ClinicalTrials.gov record for the AMEERA-5 breast cancer study is available, including its terminated status, study design and outcomes, eligibility criteria, locations, and linked study documents.SummaryDifference100%

- Check18 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedA banner announces NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision number changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check46 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the previously visible study record details with a basic error layout and a Home link. This indicates the page is inaccessible.SummaryDifference18%

Stay in the know with updates to Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.